79 research outputs found
Hand therapy or not following collagenase treatment for Dupuytren's contracture? Protocol for a randomised controlled trial
Background: Dupuytren’s contracture (DC) is a fibrotic hand condition in which one or more fingers develop
progressive flexion deformities. Quality of life is diminished due to disabling limitations in performing everyday
activities. For DC patients treated with collagenase, referral for subsequent hand therapy is inconsistent. It is
unknown whether subsequent hand therapy is beneficial compared to no therapy. The purpose of this study is to
determine whether hand therapy improves DC patients’ performance of and satisfaction with performing everyday
activities one year after collagenase treatment.
Methods: We will conduct a randomised controlled trial with two treatment groups (hand therapy vs. control) of
DC patients who have received collagenase treatment. DC patients with contracted metacarpophalangeal joint(s)
(MCPJ) (hand therapy, n = 40; control, n = 40) and those with proximal interphalangeal joint(s) (PIPJ) involvement
(hand therapy, n = 40; control, n = 40) comprise two subgroups, and we will study if the treatment effect will be
different between both groups (n = 160). Patients with a previous injury or treatment for DC in the treatment finger
are excluded. Hand therapy includes oedema and scar management, splinting, movement exercises, and practice of
everyday activities. The main outcome variable is patients’ performance of and satisfaction with performing
everyday activities, as assessed with the Canadian Occupational Performance Measure. Secondary outcomes are DCspecific activity problems, as assessed with the Unité Rhumatologique des Affections de la Main scale, and active/
passive flexion/extension of treated joints and grip force using standard measuring tools, and self-reported pain
level. Demographic and clinical variables, degree of scarring, cold hypersensitivity, number of occupational sickleave days are collected. Self-reported global impression of change will be used to assess patient satisfaction with
change in hand function. Assessments are done pre-injection and 6 weeks, 4 months, and 1 year later. Standard
univariate and multivariate statistical analyses will be used to evaluate group differences.
Discussion: This study aims to assess whether hand therapy is beneficial for activity-related, biomechanical, and
clinical outcomes in DC patients after collagenase treatment. The results will provide an objective basis for
determining whether hand therapy should be conducted after collagenase treatment
Complex Kerr Geometry and Nonstationary Kerr Solutions
In the frame of the Kerr-Schild approach, we consider the complex structure
of Kerr geometry which is determined by a complex world line of a complex
source. The real Kerr geometry is represented as a real slice of this complex
structure. The Kerr geometry is generalized to the nonstationary case when the
current geometry is determined by a retarded time and is defined by a
retarded-time construction via a given complex world line of source. A general
exact solution corresponding to arbitrary motion of a spinning source is
obtained. The acceleration of the source is accompanied by a lightlike
radiation along the principal null congruence. It generalizes to the rotating
case the known Kinnersley class of "photon rocket" solutions.Comment: v.3, revtex, 16 pages, one eps-figure, final version (to appear in
PRD), added the relation to twistors and algorithm of numerical computations,
English is correcte
Universal neural field computation
Turing machines and G\"odel numbers are important pillars of the theory of
computation. Thus, any computational architecture needs to show how it could
relate to Turing machines and how stable implementations of Turing computation
are possible. In this chapter, we implement universal Turing computation in a
neural field environment. To this end, we employ the canonical symbologram
representation of a Turing machine obtained from a G\"odel encoding of its
symbolic repertoire and generalized shifts. The resulting nonlinear dynamical
automaton (NDA) is a piecewise affine-linear map acting on the unit square that
is partitioned into rectangular domains. Instead of looking at point dynamics
in phase space, we then consider functional dynamics of probability
distributions functions (p.d.f.s) over phase space. This is generally described
by a Frobenius-Perron integral transformation that can be regarded as a neural
field equation over the unit square as feature space of a dynamic field theory
(DFT). Solving the Frobenius-Perron equation yields that uniform p.d.f.s with
rectangular support are mapped onto uniform p.d.f.s with rectangular support,
again. We call the resulting representation \emph{dynamic field automaton}.Comment: 21 pages; 6 figures. arXiv admin note: text overlap with
arXiv:1204.546
Resonance expansions in quantum mechanics
The goal of this contribution is to discuss various resonance expansions that
have been proposed in the literature.Comment: 10 pages and 1 figure; presented at the Istanbul workshop on
pseudo-Hermitian Hamiltonian
On Mason's rigidity theorem
Following an argument proposed by Mason, we prove that there are no
algebraically special asymptotically simple vacuum space-times with a smooth,
shear-free, geodesic congruence of principal null directions extending
transversally to a cross-section of Scri. Our analysis leaves the door open for
escaping this conclusion if the congruence is not smooth, or not transverse to
Scri. One of the elements of the proof is a new rigidity theorem for the
Trautman-Bondi mass.Comment: minor typos correcte
The Physics of Star Cluster Formation and Evolution
© 2020 Springer-Verlag. The final publication is available at Springer via https://doi.org/10.1007/s11214-020-00689-4.Star clusters form in dense, hierarchically collapsing gas clouds. Bulk kinetic energy is transformed to turbulence with stars forming from cores fed by filaments. In the most compact regions, stellar feedback is least effective in removing the gas and stars may form very efficiently. These are also the regions where, in high-mass clusters, ejecta from some kind of high-mass stars are effectively captured during the formation phase of some of the low mass stars and effectively channeled into the latter to form multiple populations. Star formation epochs in star clusters are generally set by gas flows that determine the abundance of gas in the cluster. We argue that there is likely only one star formation epoch after which clusters remain essentially clear of gas by cluster winds. Collisional dynamics is important in this phase leading to core collapse, expansion and eventual dispersion of every cluster. We review recent developments in the field with a focus on theoretical work.Peer reviewe
Stonefly (Plecoptera) fauna of streams in a mountainous area of Central Brazil: abiotic factors and nymph density
Ephemeroptera, Plecoptera and Trichoptera assemblages in two Atlantic Rainforest streams, Southeastern Brazil
The Influence of Age and Sex on Genetic Associations with Adult Body Size and Shape : A Large-Scale Genome-Wide Interaction Study
Genome-wide association studies (GWAS) have identified more than 100 genetic variants contributing to BMI, a measure of body size, or waist-to-hip ratio (adjusted for BMI, WHRadjBMI), a measure of body shape. Body size and shape change as people grow older and these changes differ substantially between men and women. To systematically screen for age-and/or sex-specific effects of genetic variants on BMI and WHRadjBMI, we performed meta-analyses of 114 studies (up to 320,485 individuals of European descent) with genome-wide chip and/or Metabochip data by the Genetic Investigation of Anthropometric Traits (GIANT) Consortium. Each study tested the association of up to similar to 2.8M SNPs with BMI and WHRadjBMI in four strata (men 50y, women 50y) and summary statistics were combined in stratum-specific meta-analyses. We then screened for variants that showed age-specific effects (G x AGE), sex-specific effects (G x SEX) or age-specific effects that differed between men and women (G x AGE x SEX). For BMI, we identified 15 loci (11 previously established for main effects, four novel) that showed significant (FDR= 50y). No sex-dependent effects were identified for BMI. For WHRadjBMI, we identified 44 loci (27 previously established for main effects, 17 novel) with sex-specific effects, of which 28 showed larger effects in women than in men, five showed larger effects in men than in women, and 11 showed opposite effects between sexes. No age-dependent effects were identified for WHRadjBMI. This is the first genome-wide interaction meta-analysis to report convincing evidence of age-dependent genetic effects on BMI. In addition, we confirm the sex-specificity of genetic effects on WHRadjBMI. These results may providefurther insights into the biology that underlies weight change with age or the sexually dimorphism of body shape.Peer reviewe
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980�2015: a systematic analysis for the Global Burden of Disease Study 2015
Background Improving survival and extending the longevity of life for all populations requires timely, robust evidence on local mortality levels and trends. The Global Burden of Disease 2015 Study (GBD 2015) provides a comprehensive assessment of all-cause and cause-specific mortality for 249 causes in 195 countries and territories from 1980 to 2015. These results informed an in-depth investigation of observed and expected mortality patterns based on sociodemographic measures. Methods We estimated all-cause mortality by age, sex, geography, and year using an improved analytical approach originally developed for GBD 2013 and GBD 2010. Improvements included refinements to the estimation of child and adult mortality and corresponding uncertainty, parameter selection for under-5 mortality synthesis by spatiotemporal Gaussian process regression, and sibling history data processing. We also expanded the database of vital registration, survey, and census data to 14�294 geography�year datapoints. For GBD 2015, eight causes, including Ebola virus disease, were added to the previous GBD cause list for mortality. We used six modelling approaches to assess cause-specific mortality, with the Cause of Death Ensemble Model (CODEm) generating estimates for most causes. We used a series of novel analyses to systematically quantify the drivers of trends in mortality across geographies. First, we assessed observed and expected levels and trends of cause-specific mortality as they relate to the Socio-demographic Index (SDI), a summary indicator derived from measures of income per capita, educational attainment, and fertility. Second, we examined factors affecting total mortality patterns through a series of counterfactual scenarios, testing the magnitude by which population growth, population age structures, and epidemiological changes contributed to shifts in mortality. Finally, we attributed changes in life expectancy to changes in cause of death. We documented each step of the GBD 2015 estimation processes, as well as data sources, in accordance with Guidelines for Accurate and Transparent Health Estimates Reporting (GATHER). Findings Globally, life expectancy from birth increased from 61·7 years (95 uncertainty interval 61·4�61·9) in 1980 to 71·8 years (71·5�72·2) in 2015. Several countries in sub-Saharan Africa had very large gains in life expectancy from 2005 to 2015, rebounding from an era of exceedingly high loss of life due to HIV/AIDS. At the same time, many geographies saw life expectancy stagnate or decline, particularly for men and in countries with rising mortality from war or interpersonal violence. From 2005 to 2015, male life expectancy in Syria dropped by 11·3 years (3·7�17·4), to 62·6 years (56·5�70·2). Total deaths increased by 4·1 (2·6�5·6) from 2005 to 2015, rising to 55·8 million (54·9 million to 56·6 million) in 2015, but age-standardised death rates fell by 17·0 (15·8�18·1) during this time, underscoring changes in population growth and shifts in global age structures. The result was similar for non-communicable diseases (NCDs), with total deaths from these causes increasing by 14·1 (12·6�16·0) to 39·8 million (39·2 million to 40·5 million) in 2015, whereas age-standardised rates decreased by 13·1 (11·9�14·3). Globally, this mortality pattern emerged for several NCDs, including several types of cancer, ischaemic heart disease, cirrhosis, and Alzheimer's disease and other dementias. By contrast, both total deaths and age-standardised death rates due to communicable, maternal, neonatal, and nutritional conditions significantly declined from 2005 to 2015, gains largely attributable to decreases in mortality rates due to HIV/AIDS (42·1, 39·1�44·6), malaria (43·1, 34·7�51·8), neonatal preterm birth complications (29·8, 24·8�34·9), and maternal disorders (29·1, 19·3�37·1). Progress was slower for several causes, such as lower respiratory infections and nutritional deficiencies, whereas deaths increased for others, including dengue and drug use disorders. Age-standardised death rates due to injuries significantly declined from 2005 to 2015, yet interpersonal violence and war claimed increasingly more lives in some regions, particularly in the Middle East. In 2015, rotaviral enteritis (rotavirus) was the leading cause of under-5 deaths due to diarrhoea (146�000 deaths, 118�000�183�000) and pneumococcal pneumonia was the leading cause of under-5 deaths due to lower respiratory infections (393�000 deaths, 228�000�532�000), although pathogen-specific mortality varied by region. Globally, the effects of population growth, ageing, and changes in age-standardised death rates substantially differed by cause. Our analyses on the expected associations between cause-specific mortality and SDI show the regular shifts in cause of death composition and population age structure with rising SDI. Country patterns of premature mortality (measured as years of life lost YLLs) and how they differ from the level expected on the basis of SDI alone revealed distinct but highly heterogeneous patterns by region and country or territory. Ischaemic heart disease, stroke, and diabetes were among the leading causes of YLLs in most regions, but in many cases, intraregional results sharply diverged for ratios of observed and expected YLLs based on SDI. Communicable, maternal, neonatal, and nutritional diseases caused the most YLLs throughout sub-Saharan Africa, with observed YLLs far exceeding expected YLLs for countries in which malaria or HIV/AIDS remained the leading causes of early death. Interpretation At the global scale, age-specific mortality has steadily improved over the past 35 years; this pattern of general progress continued in the past decade. Progress has been faster in most countries than expected on the basis of development measured by the SDI. Against this background of progress, some countries have seen falls in life expectancy, and age-standardised death rates for some causes are increasing. Despite progress in reducing age-standardised death rates, population growth and ageing mean that the number of deaths from most non-communicable causes are increasing in most countries, putting increased demands on health systems. Funding Bill & Melinda Gates Foundation. © 2016 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY licens
- …